VB50 Stock Chart & Stats
€0.01
>-€0.01(-28.57%)
At close: 4:00 PM EDT
€0.01
>-€0.01(-28.57%)
Day’s Range― - ―
52-Week Range€0.01 - €0.01
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€231.36K
Enterprise Value€292.94K
Total Cash (Recent Filing)€111.00
Total Debt (Recent Filing)€10.13K
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding74,413,270
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-6.18
Price to Sales (P/S)0.00
P/FCF Ratio-1.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
VB50 FAQ
What was Albert Labs International’s price range in the past 12 months?
Albert Labs International lowest stock price was €0.01 and its highest was €0.01 in the past 12 months.
What is Albert Labs International’s market cap?
Albert Labs International’s market cap is €231.36K.
When is Albert Labs International’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Albert Labs International’s earnings last quarter?
Albert Labs International released its earnings results on Nov 29, 2023. The company reported €0 earnings per share for the quarter.
Is Albert Labs International overvalued?
According to Wall Street analysts Albert Labs International’s price is currently Overvalued.
Does Albert Labs International pay dividends?
Albert Labs International does not currently pay dividends.
What is Albert Labs International’s EPS estimate?
Albert Labs International’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Albert Labs International have?
Albert Labs International has 74,413,270 shares outstanding.
What happened to Albert Labs International’s price movement after its last earnings report?
Albert Labs International reported an EPS of €0 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Albert Labs International?
Currently, no hedge funds are holding shares in DE:VB50
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Albert Labs International
Albert Labs International Corp. operates as a clinical research and drug development company. The company focuses on treating patients with urgent and unmet needs, including critical mental health indications. It develops psilocybin-assisted therapies to improve mental health conditions, including anxiety, depression, and oncology-related distress. The company is based in Burnaby, Canada.